Is hyponatremia a novel marker of inflammation in patients with COVID-19?
Nephrol Dial Transplant
.
2023 Jul 31;38(8):1921-1924.
doi: 10.1093/ndt/gfad111.
Authors
Juan Carlos Ayus
1
,
Kamyar Kalantar-Zadeh
1
2
,
Ekamol Tantisattamo
1
,
Connie M Rhee
1
,
Armando L Negri
3
Affiliations
1
Division of Nephrology, Hypertension, and Kidney Transplantation, University of California Irvine, Orange, CA, USA.
2
Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, CA, USA.
3
Nephrology Section, Instituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina.
PMID:
37245062
DOI:
10.1093/ndt/gfad111
No abstract available
Publication types
Letter
MeSH terms
COVID-19* / complications
Humans
Hyponatremia* / diagnosis
Hyponatremia* / etiology
Inflammation
Sodium
Substances
Sodium